McCarthy Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

McCarthy Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-654	Closed	-$48K	–	72
2022 Q1	$48K	Hold	654	–	–	0.03%	81
2021 Q4	$41K	Hold	654	–	–	0.03%	97
2021 Q3	$39K	Hold	654	–	–	0.03%	96
2021 Q2	$44K	Hold	654	–	–	0.03%	98
2021 Q1	$41K	Hold	654	–	–	0.03%	103
2020 Q4	$41K	Buy	+654	New	+$40.2K	0.03%	97

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

McCarthy Asset Management's BMY Position: Q2 2022 in Review

McCarthy Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 654 shares — an estimated $48K sold.

McCarthy Asset Management first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $48K in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

McCarthy Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 654 Bristol-Myers Squibb shares in Q2 2022, an estimated $48K.
McCarthy Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's Bristol-Myers Squibb position peaked at $48K in Q1 2022.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.